David V. Gold

CD74 Is Expressed by Multiple Myeloma and Is a Promising Target for Therapy

J. D. Burton, Scott Ely, Praveen K. Reddy et al. · Clinical Cancer Research · 2004 · 158 citations

Life Sciences, Immunology, Oncology +17

Milatuzumab–SN-38 Conjugates for the Treatment of CD74+ Cancers

Serengulam V. Govindan, Thomas M. Cardillo, Robert M. Sharkey et al. · Molecular Cancer Therapeutics · 2013 · 133 citations

Pharmacy, Medicinal Chemistry, Oncology +17

New MUC1 Serum Immunoassay Differentiates Pancreatic Cancer From Pancreatitis

David V. Gold, David E. Modrak, Zhiliang Ying et al. · Journal of Clinical Oncology · 2005 · 128 citations · Full text

Medicine, Oncology, Pathology +17

PAM4-Reactive MUC1 Is a Biomarker for Early Pancreatic Adenocarcinoma

David V. Gold, Zarir E. Karanjawala, David E. Modrak et al. · Clinical Cancer Research · 2007 · 93 citations

Medicine, Oncology, Pathology +16

Fractionated radioimmunotherapy with ⁹⁰ Y‐clivatuzumab tetraxetan and low‐dose gemcitabine is active in advanced pancreatic cancer

Allyson J. Ocean, Kenneth Pennington, Michael J. Guarino et al. · Cancer · 2012 · 84 citations · Full text

Medicine, Oncology, Pharmacotherapy +11